[MOL] Re: Prostate Cancer [01246] Medicine On Line


[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

[MOL] Re: Prostate Cancer






>
> | GUILLONNEAU B, Vallancien G.
> | Laparoscopic radical prostatectomy: the Montsouris technique.
> | J Urol 2000;163:1643-9.
> |
> | Abstract:
> http://www.amedeo.com/lit.cfm?uid=A10799152&aid=B120240&dopt=r&s=prc
> |
> | WEIR EG, Partin AW, Epstein JI.
> | Correlation of serum prostate specific antigen and quantitative
> immunohistochemistry.
> | J Urol 2000;163:1739-42.
> |
> | Abstract:
> http://www.amedeo.com/lit.cfm?uid=A10799172&aid=B120240&dopt=r&s=prc
> |
> | NOGUCHI M, Stamey TA, Neal JE, Yemoto CE.
> | An analysis of 148 consecutive transition zone cancers: clinical and
> histological characteristics.
> | J Urol 2000;163:1751-5.
> |
> | Abstract:
> http://www.amedeo.com/lit.cfm?uid=A10799175&aid=B120240&dopt=r&s=prc
> |
> | MEJEAN A, Vona G, Nalpas B, et al.
> | Detection of circulating prostate derived cells in patients with
prostate
> adenocarcinoma is an independent risk factor for tumor
> | recurrence.
> | J Urol 2000;163:2022-9.
> |
> | Abstract:
> http://www.amedeo.com/lit.cfm?uid=A10799250&aid=B120240&dopt=r&s=prc
> |
> | THALMANN GN, Sikes RA, Wu TT, et al.
> | LNCaP progression model of human prostate cancer: Androgen-independence
> and osseous metastasis.
> | Prostate 2000;44:91-103.
> |
> | Abstract:
> http://www.amedeo.com/lit.cfm?uid=A10881018&aid=B120240&dopt=r&s=prc
> |
> | PACIS RA, Pilat MJ, Pienta KJ, et al.
> | Decreased galectin-3 expression in prostate cancer.
> | Prostate 2000;44:118-123.
> |
> | Abstract:
> http://www.amedeo.com/lit.cfm?uid=A10881021&aid=B120240&dopt=r&s=prc
> |
> | PLONOWSKI A, Schally AV, Varga JL, et al.
> | Potentiation of the inhibitory effect of growth hormone-releasing
hormone
> antagonists on PC-3 human prostate cancer by bombesin
> | antagonists indicative of interference with both IGF and EGF pathways.
> | Prostate 2000;44:172-180.
> |
> | Abstract:
> http://www.amedeo.com/lit.cfm?uid=A10881027&aid=B120240&dopt=r&s=prc


------------------------------------------------------------------------
This is an automatically-generated notice.  If you'd like to be removed
from the mailing list, please visit the Medicine-On-Line Discussion Forum
at <http://www.meds.com/con_faq.html>, or send an email message to:
majordomo@lists.meds.com
with the subject line blank and the body of the message containing the line:
unsubscribe mol-cancer your-email-address
where the phrase your-email-address is replaced with your actual email
address.
------------------------------------------------------------------------